Heterozygous deficiency of endoglin decreases insulin and hepatic triglyceride levels during high fat diet
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10347/21951
Files in this item
Metadata
Title: | Heterozygous deficiency of endoglin decreases insulin and hepatic triglyceride levels during high fat diet |
Author: | Beiroa Tarrío, Daniel Romero Picó, Amparo Langa, Carmen Bernabeu, Carmelo López Pérez, Miguel Antonio López Novoa, José M. Nogueiras Pozo, Rubén Diéguez González, Carlos |
Affiliation: | Universidade de Santiago de Compostela. Centro de Investigación en Medicina Molecular e Enfermidades Crónicas Universidade de Santiago de Compostela. Departamento de Fisioloxía |
Date of Issue: | 2013 |
Publisher: | PLOS |
Citation: | Beiroa D, Romero-Picó A, Langa C, Bernabeu C, López M, López-Novoa JM, et al. (2013) Heterozygous Deficiency of Endoglin Decreases Insulin and Hepatic Triglyceride Levels during High Fat Diet. PLoS ONE 8(1): e54591. https://doi.org/10.1371/journal.pone.0054591 |
Abstract: | Endoglin is a transmembrane auxiliary receptor for transforming growth factor-beta (TGF-beta) that is predominantly expressed on proliferating endothelial cells. It plays a wide range of physiological roles but its importance on energy balance or insulin sensitivity has been unexplored. Endoglin deficient mice die during midgestation due to cardiovascular defects. Here we report for first time that heterozygous endoglin deficiency in mice decreases high fat diet-induced hepatic triglyceride content and insulin levels. Importantly, these effects are independent of changes in body weight or adiposity. At molecular level, we failed to detect relevant changes in the insulin signalling pathway at basal levels in liver, muscle or adipose tissues that could explain the insulin-dependent effect. However, we found decreased triglyceride content in the liver of endoglin heterozygous mice fed a high fat diet in comparison to their wild type littermates. Overall, our findings indicate that endoglin is a potentially important physiological mediator of insulin levels and hepatic lipid metabolism. |
Publisher version: | https://doi.org/10.1371/journal.pone.0054591 |
URI: | http://hdl.handle.net/10347/21951 |
DOI: | 10.1371/journal.pone.0054591 |
E-ISSN: | 1932-6203 |
Rights: | © 2013 Beiroa et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited |
Collections
-
- CIMUS-Artigos [202]
- FIS-Artigos [105]
Except where otherwise noted, this item's license is described as © 2013 Beiroa et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited